ArticleJournal of patient-reported outcomes2026
Evaluation of the construct validity of the Michigan Fatigability Index (MIFI) short forms: a cross-sectional survey study.
Article in Journal of patient-reported outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe Michigan Fatigability Index (MIFI) is a patient reported outcome (PRO) measure that was developed in people with multiple sclerosis (MS) or fibromyalgia (FM). The MIFI consists of three items banks and corresponding 6-item short forms that assess physical fatigability, mental fatigability, or emotional fatigability. This report details examination of convergent and known-groups validity (i.e., construct validity) of the MIFI short forms for MS and FM. METHODOLOGY: A US web-based cross-sectional survey was distributed to n = 2650 participants (FM n = 1242; MS n = 1408) who completed the MIFI measure and measures of fatigue intensity, severity, impact, fatigability, physical and cognitive functioning, anxiety, and depressive symptoms to establish convergent validity. Tests of known groups validity were based on disease severity scores for MS and FM and PROMIS measures of global physical and mental health scores, which were dichotomized into upper and lower tertile health groups.
resultsConvergent validity of the MIFI short forms was supported by moderate to high correlations (r = > 0.60) with measures of similar constructs. Each MIFI fatigability short form was able to distinguish between lower and upper tertiles on global physical and mental health with large effects (η²>0.3), and between lower and upper disease severity subgroups with small to large effects, supporting known groups validity.
conclusionsResults support the construct validity of the MIFI physical fatigability, mental fatigability, and emotional fatigability short forms for MS and FM. The MIFI measures, which are brief and developed specifically for use in clinical populations with high fatigue burden, should be considered for use in clinical and research applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.